Retina/Vitreous

Top Story

Depo-Medrol warning tops OSN’s news of the week

April 21, 2019

First patient dosed in Innovent wet AMD trial

April 18, 2019
Innovent Biologics has dosed the first patient in a phase 1 trial of IBI302, the company’s wet age-related macular degeneration treatment candidate, according to a…

Visual acuity gains reported in phase 3 trial of Leber hereditary optic neuropathy treatment

April 18, 2019
GenSight Biologics’ gene therapy treatment candidate for Leber hereditary optic neuropathy showed continuous recovery of visual function in a phase 3 trial…
In the Journals

Twice weekly fish intake reduces risk of AMD

April 17, 2019
A diet that includes eating fish twice a week as well as daily intake of fruits and vegetables was associated with reduced risk of developing age-related macular…
More Headlines »
Experimental Science

Therapeutic Window of Retinal Photocoagulation With Green (532-nm) and Yellow (577-nm) Lasers

Ophthalmic Surgery, Lasers and Imaging Retina, July 2012, Volume 43 Issue 4
The 577-nm (yellow) laser provides an alternative to the 532-nm (green) laser in retinal photocoagulation, with…
More »
CME

Long-term Management of Neovascular AMD: Meeting the Need for Improvement

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Age-related macular degeneration (AMD) is a leading cause of irreversible blindness and visual impairment. As…
More »
Video
Meeting News

VIDEO: Missed neuro-ophthalmology diagnoses rank high for medicolegal action

March 30, 2019
More »

Depo-Medrol warning tops OSN’s news of the week

April 21, 2019
Here are some of the top stories on Healio.com/OSN in the past week:

First patient dosed in Innovent wet AMD trial

April 18, 2019
Innovent Biologics has dosed the first patient in a phase 1 trial of IBI302, the company’s wet age-related macular degeneration treatment…

Visual acuity gains reported in phase 3 trial of Leber hereditary optic neuropathy treatment

April 18, 2019
GenSight Biologics’ gene therapy treatment candidate for Leber hereditary optic neuropathy showed continuous recovery of visual function in a…

In the Journals

Twice weekly fish intake reduces risk of AMD

April 17, 2019
A diet that includes eating fish twice a week as well as daily intake of fruits and vegetables was associated with reduced risk of developing…

Ophthotech rebrands as Iveric bio

April 17, 2019
Ophthotech is changing its name to Iveric Bio and will focus on developing novel gene therapy solutions for orphan inherited retinal diseases…

FDA places clinical hold on IND application for Adverum’s wet AMD gene therapy

April 16, 2019
The FDA has placed a clinical hold on Adverum Biotechnologies’ investigational new drug application for its gene therapy candidate for wet…

Biologics license application accepted for brolucizumab for wet AMD

April 15, 2019
The FDA has accepted a biologics license application for brolucizumab for the treatment of neovascular age-related macular degeneration, Novartis…

ProQR initiates phase 2/3 trial of LCA10 treatment candidate

April 15, 2019
ProQR Therapeutics has begun dosing in a phase 2/3 trial of sepofarsen, its treatment candidate for Leber’s congenital amaurosis 10, according…

In the Journals

Remove Depo-Medrol from ophthalmological surgical suites to avoid accidental retinal toxicity

April 15, 2019
Methylprednisolone acetate, which has similar packaging and appearance to triamcinolone acetonide, should be removed from shelves of ophthalmological…

Eyenuk launches AI diabetic retinopathy screening service

April 12, 2019
Eyenuk has launched its EyeScreen Human + AI Diagnostic Service for diabetic retinopathy, according to a press release. The artificial intelligence…

AGTC announces enrollment milestones in two gene therapy trials

April 10, 2019
Applied Genetic Technologies Corporation has completed enrollment in two phase 1/2 clinical trials of adeno-associated virus-based gene therapies…

Meeting News

Collaboration between ophthalmologists, rheumatologists needed for immunosuppression

April 8, 2019
CHICAGO — Rheumatologists should make greater efforts to collaborate with ophthalmologists to better care for patients with inflammatory and…

OSN’s top news of the week

April 7, 2019
Here are some top stories on Healio.com/OSN from the past week:

Meeting NewsVideo

VIDEO: Dosing regimens for AMD aim to optimize best vision

April 6, 2019
WAIKOLOA, Hawaii — At Retina 2019, Carl D. Regillo, MD, FACS, of Wills Eye Hospital in Philadelphia, gives his presentation on dosing regimens…

Iluvien approved for new indication in UK

April 5, 2019
The United Kingdom has added a new indication for Iluvien, approving it for the prevention of relapse in recurrent noninfectious uveitis affecting…

Meeting NewsVideo

VIDEO: Frequency of anti-VEGF injections lessens after first year of treatment

April 5, 2019
WAIKOLOA, Hawaii — At Retina 2019, Andrew A. Moshfeghi, MD, MBA, associate professor of clinical ophthalmology at the USC Roski Eye…

Top stories from Retina World Congress

April 5, 2019
The Retina World Congress was held in Fort Lauderdale, Florida, from March 21 to 24. Here are the top five most-read articles or most-watched video…

Oxurion completes phase 2 enrollment for anti-PlGF, anti-VEGF combination therapy for DME

April 4, 2019
Enrollment is complete in a phase 2 trial of the anti-PlGF THR-317 in combination with the anti-VEGF ranibizumab for the treatment of diabetic…

Meeting News

Vitreous findings may play future role in ROP screening

April 2, 2019
SAN DIEGO — Hyperreflective vitreous opacities seen on hand-held OCT are strongly correlated with the presence of retinopathy of prematurity…

MAPLE trial shows less intraocular inflammation after abicipar use

April 2, 2019
There was a decrease in the incidence of intraocular inflammation in the 28-week MAPLE study of abicipar pegol, Allergan and Molecular Partners…

More Headlines »